Clinicopathological and intraoperative parameters associated with postoperative hepatic complications

Hepato-Gastroenterology

Volumn 54, Issue 75, 2007, Pages 839-843

  Nanashima, Atsushi ^a,b   Sumida, Yorihisa ^a   Abo, Takafumi ^a   Tanaka, Kenji ^a   Takeshita, Hiroaki ^a   Hidaka, Shigekazu ^a   Yano, Hiroshi ^a   Sawai, Terumitsu ^a   Obatake, Masayuki ^a   Yasutake, Toru ^a   Nagayasu, Takeshi ^a  

^a NAGASAKI UNIVERSITY   (Japan)

^b NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

Author keywords

Liver dysfunction; Liver resection; Post hepatectomy complications; Prognostic parameters

Indexed keywords

ALANINE AMINOTRANSFERASE; CHOLESTEROL; GALACTOSYL HUMAN SERUM ALBUMIN TC 99M; HUMAN SERUM ALBUMIN TC 99M; PROTHROMBIN; UNCLASSIFIED DRUG;

ABDOMINAL INFECTION; ADULT; AGED; ARTICLE; ASCITES; BLEEDING; CHRONIC HEPATITIS; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRAOPERATIVE PERIOD; JAUNDICE; LIVER CIRRHOSIS; LIVER DYSFUNCTION; LIVER FAILURE; LIVER INJURY; LIVER RESECTION; LIVER SCINTISCANNING; LIVER TUMOR; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OUTCOME ASSESSMENT; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SCORING SYSTEM; UNIVARIATE ANALYSIS; VIRUS HEPATITIS;

AGED; CHOLESTEROL; FEMALE; HEPATECTOMY; HUMANS; HYALURONIC ACID; LIVER DISEASES; LIVER NEOPLASMS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROTHROMBIN;

EID: 34250194591     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Poon RT, Fan ST, Lo CM, Liu CL, Lam CM, Yuen WK, Yeung C, Wong J: Improving perioperative outcome expands the role of hepatectomy in management of benign and malignant hepatobiliary diseases: analysis of 1222 consecutive patients from a prospective database. Ann Surg 2004; 240:698-708.
2. Kokudo N, Vera DR, Tada K, Koizumi M, Seki M, Matsubara T, Ohta H, Yamaguchi T, Takahashi T, Nakajima T, Muto T: Predictors of successful hepatic resection: Prognostic usefulness of hepatic asialoglycoprotein receptor analysis. World J Surg 2002; 26:1342-1347.
3. Fan T, Lo CM, Liu CL, Lam CM, Yuen WK, Yeung C, Wong J: Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths. Ann Surg 1999; 229:322-330.
4. Fan ST: Methods and related drawbacks in the estimation of surgical risks in cirrhotic patients undergoing hepatectomy. Hepatogastroenterology 2002; 49:17-20.
5. Ishikawa M, Yogita S, Miyake H, Fukuda Y, Harada M, Wada D, Tashiro S: Clarification of risk factors for hepatectomy in patients with hepatocellular carcinoma. Hepatogastroenterology 2002; 49:1625-1631.
6. Rau HG, Schauer R, Helmberger T, Holzknecht N, von Ruckmann B, Meyer L, Buttler E, Kessler M, Zahlmann G, Schuhmann D, Schildberg FW: Impact of virtual reality imaging on hepatic liver tumor resection: calculation of risk. Langenbeck's Arch Surg 2000; 385:162-170.
7. Miyagawa S, Makuuchi M, Kawasaki S, Kakazu T: Criteria for safe hepatic resection. Am J Surg 1995; 169:589-594.
8. Hemming AW, Scudamore CH, Shackleton CR, Pudek M, Erb SR: Indocyanine green clearance as a predictor of successful hepatic resection in cirrhotic patients. Am J Surg 1992; 163:515-518.
9. Mitsumori A, Nagaya I, Kimoto S, Akaki S, Togami I, Takeda Y, Joja I, Hiraki Y: Preoperative evaluation of hepatic functional reserve following hepatectomy by technetium-99m galactosyl human serum albumin liver scintigraphy and computed tomography. Eur J Nucl Med 1998; 25:1377-1382.
10. Yachida S, Wakabayashi H, Kokudo Y, Goda F, Okada S, Maeba T, Maeta H: Measurement of serum hyaluronate as a predictor of human liver failure after major hepatectomy. World J Surg 2000; 24:359-364.
11. Hsia CY, Chau GY, King KL, Loong CC, Lui WY, Wu CW: Factors for prolonged length of stay after elective hepatectomy for hepatocellular carcinoma. The surgeon's role in the managed care era. Hepatogastroenterology 2003; 50:798-804.
12. Takasaki T, Kobayashi S, Suzuki S, Muto H, Marada M, Yamana Y, Nagaoka T: Predetermining postoperative hepatic function for hepatectomies. Int Surg 1980; 65:309-313.
13. Kubota K, Makuuchi M, Kusaka K, Kobayashi T, Miki K, Hasegawa K, Harihara Y, Takayama T: Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resection surgery for hepatic tumors. Hepatology 1997; 26:1176-1181.
14. Ishigami Y, Masuzawa M, Miyoshi E, Kato M, Tamura K, Kanda M, Awazu K, Taniguchi K, Kurita M, Hayashi N: Clinical applications of ICG finger monitor in patients with liver disease. J Hepatol 1993; 19:232-240.
15. Hwang EH, Taki J, Shuke N, Nakajima K, Kinuya S, Konishi S, Michigishi T, Aburano T, Tonami N: Preoperative assessment of residual hepatic functional reserve using 99mTc-DTPA-galactosyl-human serum albumin dynamic SPECT. J Nucl Med 1999; 40:1644-1651.
16. Anonymous: Liver cancer study group of Japan, Stage Grouping. In: Okamoto E (Ed.). Classification of Primary Liver Cancer. First Edition. Tokyo: Kanehara & Co., 1997; p. 21.
17. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, Wollman J: Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1:431-435.
18. Fujii Y, Shimada H, Endo I, Morioka D, Nagano Y, Miura Y, Tanaka K, Togo S: Risk factors of posthepatectomy liver failure after portal vein embolization. J Hepatobiliary Pancreat Surg 2003; 10:226-232.
19. Nanashima A. Yamaguchi H, Shibasaki S, Morino S, Ide N, Takeshita H, Sawai T, Nakagoe T, Nagayasu T, Ogawa Y: Relationship between indocyanine green test and technetium-99m galactosyl serum albumin scintigraphy in patients scheduled for hepatectomy: Clinical evaluation and patient outcome. Hepatol Res 2004; 28:184-190.
20. Redaelli C, Dufour JF, Wagner M, Schilling M, Husler J, Krahenbuhl L, Buchler MW, Reichen J: Preoperative Galactose elimination capacity predicts complications and survival after hepatic resection. Ann Surg 2002; 235:77-85.
21. Yoshikawa A, Kaido T, Seto S, Yamaoka S, Sato M, Ishii T, Imamura M: Hepatocyte growth factor promotes liver regeneration with prompt improvement of hyperbilirubinemia in hepatectomized cholestatic rats. J Surg Res 1998; 8:54-59.
22. Shirabe K, Shimada M, Gion T, Hasegawa H, Takenaka K, Utsunomiya T, Sugimachi K: Postoperative liver failure after major hepatic resection for hepatocellular carcinoma in the modern era with special reference to remnant liver volume. J Am Coll Surg 1999; 188:304-309.
23. Yanaga K, Honda H, Ikeda Y, Nishizaki AT, Yamamoto K, Sugimachi K: Significance of liver size in hepatic surgery. HPB Surg 1997; 10:195-199.
24. Makuuchi M, Thai BL, Takayasu K, Takayama T, Kosuge T, Gunven P, Yamazaki S, Hasegawa H, Ozaki H: Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery 1990; 107:521-527.
25. Nanashima A, Yamaguchi H, Shibasaki S, Shindo, T Nakagoe, Ayabe H: Serum level of hyaluronic acid does not correlate with changes of hepatic volume after portal vein embolization. Acta Medica Nagasakiensia 2002; 47:43-46.
26. Greenburg AG: Benefits and risks of blood transfusion in surgical patients. World J Surg 1996; 20:1189-1193.
27. Dufour DR, Lott JA, Nolte FS, Gretch DR, Koff RS, Seeff LB: Diagnosis and monitoring of hepatic injury. II. Recommendations for use of laboratory tests in screening, diagnosis, and monitoring. Clin Chem 2000; 46:2050-2068.
28. Pontinha N, Pessegueiro H, Barros H: Serum hyaluronan as a marker of liver fibrosis in asymptomatic chronic viral hepatitis B. Scand. J Clin Lab Invest 1999; 59:343-347.
29. Idobe Y, Murawaki Y, Ikuta Y, Koda M, Kawasaki H: Post-prandial serum hyaluronan concentration in patients with chronic liver disease. Intern Med 1998; 37:568-575.
30. Ramadori G, Zohrens G, Manns M, Rieder M, Dienes HP, Hess G, Meyer KH, Buschenfelde Z: Serum hyaluronate and type III procollagen aminoterminal propeptide concentration in chronic liver disease. Relationship to cirrhosis and disease activity. Eur J Clin Invest 1991; 21:323-330.
31. Nanashima A, Yamaguchi Y, Tanaka K, Shibasaki S, Tsuji T, Ide N, Hidaka S, Sawai T, Nakagoe T, Nagayasu T: Preoperative serum hyaluronic acid level as a good predictor of posthepatectomy complications. Surg Today 2004; 34:913-919.
32. Das BC, Isaji S, Kawarada Y: Analysis of 100 consecutive hepatectomies: risk factors in patients with liver cirrhosis or obstructive jaundice. World J Surg 2001; 25:266-272.